Tags: Behavior · Intermittent access · Cocaine
Project: p50_paul_meyer_2020
0 loci · 0 genes with independent associations · 0 total associated genes
| # | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
|---|
| Trait | Chi2 ratio | # genes+ | # genes++ | % genes++ | Corr | Corr P | Genes |
|---|
| Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
|---|---|---|---|---|
| Adipose | alternative polyA | 0 | 0 | 1.12 |
| Adipose | alternative TSS | 0 | 0 | 1.19 |
| Adipose | gene expression | 0 | 0 | 1.11 |
| Adipose | isoform ratio | 0 | 0 | 1.18 |
| Adipose | intron excision ratio | 0 | 0 | 1.08 |
| Adipose | mRNA stability | 0 | 0 | 1.13 |
| BLA | alternative polyA | 0 | 0 | 1.08 |
| BLA | alternative TSS | 0 | 0 | 1.07 |
| BLA | gene expression | 0 | 0 | 1.11 |
| BLA | isoform ratio | 0 | 0 | 1.09 |
| BLA | intron excision ratio | 0 | 0 | 1.06 |
| BLA | mRNA stability | 0 | 0 | 1.11 |
| Brain | alternative polyA | 0 | 0 | 1.05 |
| Brain | alternative TSS | 0 | 0 | 1.07 |
| Brain | gene expression | 0 | 0 | 1.11 |
| Brain | isoform ratio | 0 | 0 | 1.14 |
| Brain | intron excision ratio | 0 | 0 | 1.08 |
| Brain | mRNA stability | 0 | 0 | 1.12 |
| Eye | alternative polyA | 0 | 0 | 1.23 |
| Eye | alternative TSS | 0 | 0 | 1.11 |
| Eye | gene expression | 0 | 0 | 1.17 |
| Eye | isoform ratio | 0 | 0 | 1.14 |
| Eye | intron excision ratio | 0 | 0 | 1.01 |
| Eye | mRNA stability | 0 | 0 | 1.2 |
| IL | alternative polyA | 0 | 0 | 1.04 |
| IL | alternative TSS | 0 | 0 | 1.26 |
| IL | gene expression | 0 | 0 | 1.13 |
| IL | isoform ratio | 0 | 0 | 1.15 |
| IL | intron excision ratio | 0 | 0 | 1.11 |
| IL | mRNA stability | 0 | 0 | 1.23 |
| LHb | alternative polyA | 0 | 0 | 1.08 |
| LHb | alternative TSS | 0 | 0 | 1.11 |
| LHb | gene expression | 0 | 0 | 1.15 |
| LHb | isoform ratio | 0 | 0 | 1.12 |
| LHb | intron excision ratio | 0 | 0 | 1.06 |
| LHb | mRNA stability | 0 | 0 | 1.16 |
| Liver | alternative polyA | 0 | 0 | 0.96 |
| Liver | alternative TSS | 0 | 0 | 1.12 |
| Liver | gene expression | 0 | 0 | 1.11 |
| Liver | isoform ratio | 0 | 0 | 1.16 |
| Liver | intron excision ratio | 0 | 0 | 1.15 |
| Liver | mRNA stability | 0 | 0 | 1.13 |
| NAcc | alternative polyA | 0 | 0 | 1.02 |
| NAcc | alternative TSS | 0 | 0 | 1.13 |
| NAcc | gene expression | 0 | 0 | 1.13 |
| NAcc | isoform ratio | 0 | 0 | 1.12 |
| NAcc | intron excision ratio | 0 | 0 | 1.05 |
| NAcc | mRNA stability | 0 | 0 | 1.12 |
| OFC | alternative polyA | 0 | 0 | 1.09 |
| OFC | alternative TSS | 0 | 0 | 1.04 |
| OFC | gene expression | 0 | 0 | 1.15 |
| OFC | isoform ratio | 0 | 0 | 1.1 |
| OFC | intron excision ratio | 0 | 0 | 1 |
| OFC | mRNA stability | 0 | 0 | 1.17 |
| PL | alternative polyA | 0 | 0 | 1.04 |
| PL | alternative TSS | 0 | 0 | 1.06 |
| PL | gene expression | 0 | 0 | 1.12 |
| PL | isoform ratio | 0 | 0 | 1.12 |
| PL | intron excision ratio | 0 | 0 | 1.05 |
| PL | mRNA stability | 0 | 0 | 1.14 |